PH24301A - M-csf therapeutic composition - Google Patents

M-csf therapeutic composition

Info

Publication number
PH24301A
PH24301A PH35225A PH35225A PH24301A PH 24301 A PH24301 A PH 24301A PH 35225 A PH35225 A PH 35225A PH 35225 A PH35225 A PH 35225A PH 24301 A PH24301 A PH 24301A
Authority
PH
Philippines
Prior art keywords
therapeutic composition
csf
csf therapeutic
polypeptides
production
Prior art date
Application number
PH35225A
Other languages
English (en)
Inventor
Steven C Clark
Gordon G Wong
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/860,377 external-priority patent/US4879227A/en
Priority claimed from US06/940,362 external-priority patent/US4868119A/en
Application filed by Genetics Inst filed Critical Genetics Inst
Publication of PH24301A publication Critical patent/PH24301A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PH35225A 1986-05-06 1987-05-05 M-csf therapeutic composition PH24301A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/860,377 US4879227A (en) 1986-05-06 1986-05-06 Production of a recombinant human colony stimulating factor
US06/940,362 US4868119A (en) 1986-12-11 1986-12-11 Hematopoietic growth factors

Publications (1)

Publication Number Publication Date
PH24301A true PH24301A (en) 1990-05-29

Family

ID=27127565

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35225A PH24301A (en) 1986-05-06 1987-05-05 M-csf therapeutic composition

Country Status (21)

Country Link
US (1) US5573763A (no)
EP (1) EP0307402B1 (no)
JP (2) JP2579981B2 (no)
KR (1) KR960004453B1 (no)
AT (1) ATE92966T1 (no)
AU (1) AU606056B2 (no)
CA (1) CA1334942C (no)
DE (1) DE3787020T2 (no)
DK (1) DK2688A (no)
ES (1) ES2007341A6 (no)
FI (1) FI884877A0 (no)
GR (1) GR870688B (no)
HU (1) HU212277B (no)
IE (1) IE60835B1 (no)
IL (1) IL82400A0 (no)
MX (1) MX9203130A (no)
MY (1) MY101209A (no)
NO (1) NO880022L (no)
OA (1) OA09112A (no)
PH (1) PH24301A (no)
WO (1) WO1987006954A1 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117422A (en) * 1985-02-05 2000-09-12 Chiron Corporation N∇2-CSF-1(long form) and carboxy truncated fragments thereof
AU594045B2 (en) * 1985-02-05 1990-03-01 Chiron Corporation Recombinant colony stimulating factor-1
US5573930A (en) * 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
US5104650A (en) * 1985-02-05 1992-04-14 Cetus Corporation Uses of recombinant colony stimulating factor-1
US6156300A (en) * 1985-02-05 2000-12-05 Chiron Corporation Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
US5422105A (en) * 1985-02-05 1995-06-06 Cetus Oncology Corporation Use of recombinant colony stimulating factor 1
US5837229A (en) * 1985-02-05 1998-11-17 Chiron Corporation Uses of recombinant colony stimulating factor-1
US4847201A (en) * 1985-02-05 1989-07-11 Cetus Corporation DNA encoding for CSF-1 and accompanying recombinant systems
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
US4808611A (en) * 1986-07-30 1989-02-28 Immunex Corporation Use of interleukin-1 to induce development of multipotent hemopoietic cell populations
US5650297A (en) * 1986-09-17 1997-07-22 Otsuka Pharmaceutical Co., Ltd. DNA encoding human colony-stimulating factors
JP2583829B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 ヒトｍ−ｃｓｆ
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
JPH07100720B2 (ja) * 1987-07-17 1995-11-01 森永乳業株式会社 コロニー刺激因子の製造法
CA1339757C (en) 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
IL86090A (en) * 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
DE3853721T2 (de) * 1987-09-22 1995-10-19 Cetus Oncology Corp Verwendungen von rekombinantem koloniestimulierendem faktor-1.
US5260421A (en) * 1987-12-21 1993-11-09 Applied Research Systems Ars Holding N.V. Site-directed mutagenesis modified glycoprotein hormones
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
DK54589A (da) * 1988-02-08 1989-08-09 Otsuka Pharma Co Ltd Humane kolonistmulerende faktorer
JPH0610137B2 (ja) * 1988-02-29 1994-02-09 新技術事業団 ヒト単球−マクロファージコロニー刺激因子を有効成分とする造血器疾患治療剤
KR900700156A (ko) * 1988-04-27 1990-08-11 원본미기재 개선된 방사선 치료법
US5888495A (en) * 1988-05-23 1999-03-30 Genetics Institute, Inc. Method of producing storage stable M-CSF lyophilizates
US5171675A (en) * 1988-07-28 1992-12-15 Cerretti Douglas P Macrophage colony stimulating factor-γ
HU207229B (en) * 1989-01-30 1993-03-29 Schering Corp Process for producing pharmaceutical compositions containing gm-csf for treating leukocyte disfunction
EP0457804B1 (en) * 1989-02-10 1996-08-14 Cetus Oncology Corporation M-csf monoclonal antibodies that recognize a neutralizing conformational epitope
US5288487A (en) * 1989-02-28 1994-02-22 Morinaga Milk Industry Co., Ltd. Human monocyte-macrophage-CSF preparations
AU625081B2 (en) * 1989-02-28 1992-07-02 Morinaga Milk Industry Company Limited Human monocyte-macrophage-csf preparations
AU5355790A (en) * 1989-04-19 1990-11-16 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
DE69026440T2 (de) * 1989-07-27 1996-10-17 Denki Kagaku Kogyo Kk Für M-CSF kodierendes Gen und dazu gehörende rekombinante Systeme
JPH08505534A (ja) * 1993-01-13 1996-06-18 森永乳業株式会社 Ｍ−ｃｓｆ２２３の製造方法
ATE386811T1 (de) 1996-04-05 2008-03-15 Novartis Vaccines & Diagnostic Alphaviren-vektors mit eine reduzierte inhibierung der synthese von zellmakromolekülen
US6455678B1 (en) * 1996-04-26 2002-09-24 Amcell Corporation Human hematopoietic stem and progenitor cell antigen
US6383480B1 (en) * 1996-07-10 2002-05-07 Meiji Milk Products, Co., Ltd. Composition comprising midkine or pleiotrophin protein and method of increasing hematopoietic cells
WO2000018374A1 (en) * 1998-10-01 2000-04-06 Elan Pharma International, Ltd. Controlled release nanoparticulate compositions
US7108852B2 (en) 2000-03-20 2006-09-19 Warner-Lambert Company Llc Methods of treating inflammation using antibodies to M-CSF
AR045563A1 (es) * 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
EP2089049A4 (en) * 2006-11-17 2011-11-16 Biogen Idec Inc SYSTEMIC ADMINISTRATION OF COLONIAL STIMULATING FACTORS TO TREAT AMYLOID ASSOCIATED DISEASES
EP4309666A1 (en) 2022-07-21 2024-01-24 Technische Universität Dresden M-csf for use in the prophylaxis and/or treatment of viral infections in states of immunosuppression
WO2024017998A1 (en) 2022-07-21 2024-01-25 Technische Universität Dresden M-csf for use in the prophylaxis and/or treatment of viral infections in states of immunosuppression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784949A (en) * 1984-04-19 1988-11-15 Cetus Corporation Universal dominant selectable marker cassette
AU594045B2 (en) * 1985-02-05 1990-03-01 Chiron Corporation Recombinant colony stimulating factor-1
US4847201A (en) * 1985-02-05 1989-07-11 Cetus Corporation DNA encoding for CSF-1 and accompanying recombinant systems
EP0211899B1 (en) * 1985-02-05 1992-09-23 Cetus Oncology Corporation Purification of native colony stimulating factor-1
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
WO1988003173A2 (en) * 1986-10-24 1988-05-05 Cetus Corporation New forms of colony stimulating factor-1

Also Published As

Publication number Publication date
WO1987006954A1 (en) 1987-11-19
NO880022D0 (no) 1988-01-05
ATE92966T1 (de) 1993-08-15
AU7289087A (en) 1987-12-01
CA1334942C (en) 1995-03-28
GR870688B (en) 1987-09-07
ES2007341A6 (es) 1989-06-16
JPH07147989A (ja) 1995-06-13
IE870994L (en) 1987-11-06
IE60835B1 (en) 1994-08-24
DK2688A (da) 1988-03-07
IL82400A0 (en) 1987-11-30
US5573763A (en) 1996-11-12
EP0307402A4 (en) 1990-02-22
HU212277B (en) 1996-04-29
HUT47979A (en) 1989-04-28
JPH01502397A (ja) 1989-08-24
EP0307402B1 (en) 1993-08-11
JP2579981B2 (ja) 1997-02-12
AU606056B2 (en) 1991-01-31
DE3787020T2 (de) 1993-12-16
KR960004453B1 (en) 1996-04-06
FI884877A (fi) 1988-10-21
KR880701288A (ko) 1988-07-26
EP0307402A1 (en) 1989-03-22
NO880022L (no) 1988-01-05
MX9203130A (es) 1992-07-01
MY101209A (en) 1991-08-17
DK2688D0 (da) 1988-01-05
DE3787020D1 (de) 1993-09-16
FI884877A0 (fi) 1988-10-21
OA09112A (en) 1991-10-31

Similar Documents

Publication Publication Date Title
PH24301A (en) M-csf therapeutic composition
NZ221046A (en) Interleukin-3 and interleukin-3 like polypeptides from primates, pharmaceutical compositions and recombinant methods for producing the polypeptides
HUT40145A (en) Process for producing polypeptides and pharmaceutical compositions containing them
IL77396A (en) Pharmaceutical compositions containing bicyclic heteroarylpiperazine derivatives,certain such novel compounds and their preparation
PH23778A (en) Labdan compounds,pharmaceutical compositions and use
IL99146A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
PT77370A (en) Process for preparing new pyrazolo <3,4-b> piridine derivatives and pharmaceutical preparations containing the same
MY100499A (en) Substituted thiacycloalkeno (3, 2-b) pyridines, methods of preparation compositions and method of use
IE871358L (en) Interferon for carcinoma
EP0257631A3 (en) Oxolabdanes, a process for their preparation and their use as medicaments
MY104529A (en) New selenophen derivatives, a preparation process of the same and therapeutical compositions containing them
ES8606375A1 (es) Un procedimiento para preparar un derivado de aminoprpilaminobleomicina
ES8203371A1 (es) Procedimiento de preparar indolo(2,3,3,4)pirido(2,1-b)quina-zolin-5-onas
UA19844A (uk) Склад для лікуваhhя пародоhтиту
HUT44164A (en) Composition for hygieny of mouth and process for production thereof
HU900202D0 (en) Process for manufacturing of pharmaceutical compositions comprising gamma-interferon suitable to treatment of ovarion cancer